Rare solid and cystic presentation of hemangiopericytoma/ solitary fibrous tumor: a case report
暂无分享,去创建一个
Heather N. Hayenga | J. Minna | J. Hinshaw | R. Benjamin | Z. Wardak | J. Martín-Broto | Chunyu Cai | D. Fetzer | E. Pan | B. Gao | H. Hayenga | J. Kuban | Sarah White | James Strauss | B. Gao | David T. Fetzer
[1] J. Martín-Broto,et al. A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons , 2021, Cancers.
[2] R. Eils,et al. Gene expression in Solitary Fibrous Tumors (SFTs) correlates with anatomical localization and NAB2-STAT6 gene fusion variants. , 2021, The American journal of pathology.
[3] Zui Tan,et al. Hemangiopericytoma: Incidence, Treatment, and Prognosis Analysis Based on SEER Database , 2020, BioMed research international.
[4] J. Wunder,et al. RNA expression profiling reveals PRAME, a potential immunotherapy target, is frequently expressed in solitary fibrous tumors , 2020, Modern Pathology.
[5] M. Tanahashi,et al. Solitary fibrous tumor of the pleura with marked cystic degeneration: a case report , 2020, Surgical Case Reports.
[6] Z. Ryoo,et al. NAB2-STAT6 fusion protein mediates cell proliferation and oncogenic progression via EGR-1 regulation. , 2020, Biochemical and biophysical research communications.
[7] C. Poiană,et al. Cystic appearance - a new feature of solid fibrous tumours in the lacrimal gland: a case report with literature review , 2019, Diagnostic Pathology.
[8] L. Shang,et al. A DSTYK mutation activates ERK1/2 signaling to promote intraspinal dissemination in a case of solitary fibrous tumor/hemangiopericytoma , 2019, Laboratory Investigation.
[9] Heather N. Hayenga,et al. Intraspinal Dissemination and Local Recurrence of an Intracranial Hemangiopericytoma. , 2019, World neurosurgery.
[10] J. Blay,et al. Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial. , 2019, The Lancet. Oncology.
[11] I. Baldi,et al. Increasing incidence of central nervous system (CNS) tumors (2000–2012): findings from a population based registry in Gironde (France) , 2018, BMC Cancer.
[12] K. Ashkan,et al. Surveillance for metastatic hemangiopericytoma-solitary fibrous tumors-systematic literature review on incidence, predictors and diagnosis of extra-cranial disease , 2018, Journal of Neuro-Oncology.
[13] Krishnakumar Subramanian,et al. A rare case of giant multicystic solitary fibrous tumor of the orbit , 2018, Orbit.
[14] A. D. Dei Tos,et al. Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour. , 2017, European journal of cancer.
[15] T. Tominaga,et al. Intraspinal dissemination of intracranial hemangiopericytoma: Case report and literature review , 2016, Surgical neurology international.
[16] A. Bellizzi,et al. The NAB2-STAT6 gene fusion in solitary fibrous tumor can be reliably detected by anchored multiplexed PCR for targeted next-generation sequencing. , 2016, Cancer genetics.
[17] I. Judson,et al. Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience , 2015, Clinical Sarcoma Research.
[18] Su Jin Lee,et al. Successful use of pazopanib for treatment of refractory metastatic hemangiopericytoma , 2014, Clinical Sarcoma Research.
[19] S. Lo,et al. Rare Primary Central Nervous System Tumors , 2014, Rare tumors.
[20] L. Mariani,et al. Response to chemotherapy of solitary fibrous tumour: a retrospective study. , 2013, European journal of cancer.
[21] Wei-Lien Wang,et al. The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis , 2013, Clinical Sarcoma Research.
[22] R. Gomes,et al. Primary Malignant Cystic Solitary Fibrous Tumour of the Spleen , 2013, Indian Journal of Surgical Oncology.
[23] K. Pienta,et al. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing , 2013, Nature Genetics.
[24] A. D. Dei Tos,et al. Sunitinib malate in solitary fibrous tumor (SFT). , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[25] J. Wen,et al. Recurrent Meningeal Hemangiopericytoma with Multiple Metastasis and Hypoglycemia: A Case Report , 2012, Case reports in medicine.
[26] Y. Robin,et al. Solitary Fibrous Tumors and So-Called Hemangiopericytoma , 2012, Sarcoma.
[27] A. Lazar,et al. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor , 2011, Cancer.
[28] V. Elner,et al. Cystic solitary fibrous tumor of the orbit. , 2010, Archives of ophthalmology.
[29] P. Cornu,et al. Cystic Intraventricular Solitary Fibrous Tumor , 2007, American Journal of Neuroradiology.
[30] D. Kondziolka,et al. Radiosurgery for Treatment of Recurrent Intracranial Hemangiopericytomas , 2002, Neurosurgery.
[31] K. Kishi,et al. Hypoglycemia induced by secretion of high molecular weight insulin-like growth factor-II from a malignant solitary fibrous tumor of the pleura. , 2001, Internal medicine.
[32] A. Obwegeser,et al. Vascular endothelial growth factor (VEGF) is elevated in brain tumor cysts and correlates with tumor progression , 2000, Acta Neuropathologica.
[33] K. Pavelić,et al. The expression and role of insulin-like growth factor II in malignant hemangiopericytomas , 1999, Journal of Molecular Medicine.
[34] S. Nicosia,et al. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[35] B. Scheithauer,et al. Management of recurrent meningeal hemangiopericytoma , 1998, Cancer.
[36] Jianliang Chen,et al. Intracranial Meningeal Hemangiopericytomas : Articles Review and Case Report , 2019 .